# Application of Probiotic PS128 in Children With ASD

> **NCT04942522** · PHASE1 · UNKNOWN · sponsor: **Yan Hao** · enrollment: 80 (estimated)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **BIOLOGICAL:** probiotics PS128
- **DRUG:** placebo (Microcrystalline cellulose )

## Key facts

- **NCT ID:** NCT04942522
- **Lead sponsor:** Yan Hao
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-06
- **Primary completion:** 2023-06-06
- **Final completion:** 2023-10-06
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04942522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04942522, "Application of Probiotic PS128 in Children With ASD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04942522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*